BeOne Medicines AG (HKG:6160)
165.90
-1.10 (-0.66%)
Jun 26, 2026, 4:08 PM HKT
BeOne Medicines AG Employees
BeOne Medicines AG had 12,000 employees as of December 31, 2025. The number of employees increased by 1,000 or 9.09% compared to the previous year.
Employees
12,000
Change (1Y)
1,000
Growth (1Y)
9.09%
Revenue / Employee
3.73M HKD
Profits / Employee
348.71K HKD
Market Cap
244.01B
Employees Chart
Employees History
Related Stocks
| Company Name | Employees |
|---|---|
| WuXi Biologics | 13,252 |
| Innovent Biologics | 7,502 |
| Sichuan Kelun-Biotech Biopharmaceutical | 2,045 |
| Akeso | 3,761 |
| Sino Biopharmaceutical | 21,435 |
| RemeGen | 3,048 |
| Biocytogen Pharmaceuticals (Beijing) | 1,443 |
| 3SBio | 6,109 |
BeOne Medicines AG News
- 8 days ago - Baker Bros. Advisors LP's Strategic Acquisition of BeOne Medicines Ltd Shares - GuruFocus
- 16 days ago - BeOne Medicines' Foundational Hematology Franchise Leads Next Era of B-Cell Cancer Innovation at EHA 2026 - Business Upturn
- 16 days ago - BeOne Medicines' Foundational Hematology Franchise Leads Next Era of B-Cell Cancer Innovation at EHA 2026 - Business Wire
- 17 days ago - RSI Alert: BeOne Medicines (ONC) Now Oversold - Nasdaq
- 17 days ago - BeOne Medicines Presents Promising CLL Data for Patients Over 80 - GuruFocus
- 17 days ago - BeOne Medicines (ONC) Presents Encouraging Phase 3 Data on Brukinsa for CLL - GuruFocus
- 17 days ago - BeOne Medicines announces presentation of Phase 3 data in CLL patients - TheFly
- 17 days ago - BeOne Showcases Landmark Phase 3 Data in CLL Patients Aged 80+ at EHA 2026, Reinforcing BRUKINSA Benefit - Business Wire